2024-05-13T12:33:16-05:00 2023-06-30 366055558 GRANT THORNTON LLP 5955 TG LEE BLVD STE 200 ORLANDO FL 32822 990 2022-07-01 592451713 H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE INC HLEE 8137454673 12902 MAGNOLIA DRIVE TAMPA FL 33612 YVETTE M LYONS TREMONTI EVP/CFAO 8137457862 2024-05-10 1 YVETTE LYONS TREMONTI 999009999 0 MICHELE N MELCHIOR P00488037 4074815100 2 AAL1 IAL1 2022 2023-04-26 12:10:37Z DR PATRICK HWU 12902 MAGNOLIA DRIVE TAMPA FL 33612 612786595 0 X WWW.MOFFITT.ORG X 1984 FL TO PROMOTE AND SUPPORT THROUGH RESEARCH, MANAGEMENT AND OTHER MEANS OF SUPPORT. 27 27 3204 134 14858750 8468496 197374169 223705693 22518656 21838039 -12185981 58731977 2960512 5775019 210667356 310050728 833124 750767 0 0 173302253 189766622 0 0 0 106772605 111206123 280907982 301723512 -70240626 8327216 1878942555 2420012918 876961544 1190201187 1001981011 1229811731 X SEE SCHEDULE OTO PROMOTE AND SUPPORT H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE HOSPITAL, H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE LIFETIME CANCER SCREENING CENTER, AND H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE FOUNDATION THROUGH RESEARCH, MANAGEMENT, AND OTHER MEANS OF SUPPORT. 0 0 209952945 750767 21838039 THE H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE, INC. IS ARECOGNIZED LEADER IN FOCUSED, INNOVATIVE CANCER RESEARCH, A MAJORREGIONAL ONCOLOGY REFERRAL CENTER, AND A NATIONAL CANCER INSTITUTE DESIGNATED COMPREHENSIVE CANCER CENTER.SEE SCHEDULE O FOR CONTINUATIONBASED ON ITS SINGULAR MISSION - TO CONTRIBUTE TO THE PREVENTION ANDCURE OF CANCER - THE CANCER CENTER'S RESEARCH ACTIVITIES RELATEPRIMARILY TO THE AREAS OF BASIC SCIENCE, CANCER PREVENTION AND CONTROL, TRANSLATIONAL SCIENCE, PRE-CLINICAL AND CLINICAL INVESTIGATIONS, AND PROVIDING MANAGEMENT AND OTHER SUPPORT SERVICES AS THE SOLE CORPORATE MEMBER AND PARENT FOR THE FOLLOWING SUBSIDIARY CORPORATIONS:H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE HOSPITAL, INC. (THE HOSPITAL) WHICH PROVIDES MEDICAL AND HOSPITAL CARE, MEDICAL EDUCATION AND TRAINING, AND CLINICAL (PATIENT-RELATED) RESEARCH IN MAINTAINING HEALTH, AND PREVENTING, DETECTING, AND TREATING CANCER;H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE LIFETIME CANCERSCREENING CENTER, INC. (MOFFITT MEDICAL GROUP) WHICH EMPLOYS ANDMANAGES PHYSICIANS AND OTHER MEDICAL PROFESSIONALS WHO STAFF THEHOSPITAL, AND PROVIDE CLINICAL RESEARCH SERVICES TO THE CANCER CENTER; AND H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE FOUNDATION, INC. (THE FOUNDATION) WHICH IS THE PRINCIPAL FUND-RAISING ORGANIZATION FOR THE CANCER CENTER AND ITS SUBSIDIARIES.THE CANCER CENTER'S MULTIDISCIPLINARY CLINICAL PROGRAM STRUCTURE AND OPEN LABORATORY ARCHITECTURE PROVIDE AN ENVIRONMENT CONDUCIVE FOR TRAINING FUTURE SCIENTIFIC AND CLINICAL LEADERS IN ONCOLOGY, AND REFLECT THE CANCER CENTER'S COMMITMENT TO COLLABORATION IN ALL ASPECTS OF CANCER RESEARCH. 209952945 1 1 0 1 0 0 0 0 0 0 1 0 0 1 1 1 0 1 0 1 1 1 0 0 0 0 0 1 0 1 1 0 1 0 0 0 0 0 0 1 0 1 0 0 0 0 1 1 1 0 0 1 439 0 1 3204 1 1 1 0 0 0 0 0 0 0 0 0 1 0 X 27 27 1 0 0 0 0 0 0 1 1 0 0 1 1 1 1 1 1 1 1 1 1 X YVETTE M LYONS TREMONTI 8137457862 12902 MAGNOLIA DR TAMPA FL 33612 PATRICK HWU PRES/CEO 45.00 12.00 X 1161591 0 102275 JOHN CLEVELAND EVP-CENTER DIRECTOR & CHIEF SCI OFF. 55.00 1.00 X 857654 0 -84086 SARABDEEP SINGH EVP COO 23.00 34.00 X 618920 0 89732 EDMONDO ROBINSON SVP CHIEF DIGITAL OFFICER 55.00 0.00 X 628382 0 70570 G DOUGLAS LETSON EVP-PIC 18.00 37.00 X 0 838552 -245481 JAMES J MULAY ACD TRANSLATIONAL RSCH 50.00 1.00 X 571019 0 1887 JONATHAN ZAGER CHIEF ACADEMIC OFFICER 15.00 40.00 X 0 712237 -172576 YVETTE M LYONS TREMONTI EVP-CFAO & ASST TREASURER 22.00 37.00 X 824270 0 -345650 ELSA FLORES ACD BASIC SCIENCE 50.00 0.00 X 383516 0 67129 RANDA M PERKINS CHIEF MEDICAL INFO OFFICER 50.00 0.00 X 447005 0 -7289 SHELLEY TWOROGER ACD POPULATION SCIENCE 50.00 0.00 X 367258 0 53448 BRIAN SPRINGER VP RESEARCH ADMINISTRATION 55.00 0.00 X 413755 0 -19660 HENRY REYES VP-PARTNERSHIP DEVELOPMENT 15.00 41.00 X 340850 0 45443 DONALD FUTRELL VP PLAN, DESIGN & CONS 55.00 0.00 X 351356 0 28443 AMY DURHAM VP-HUMAN RECOURCES OPS 55.00 0.00 X 362245 0 20555 JOANNA WEISS SVP FINANCE 30.00 25.00 X 448836 0 -91001 EVAN ZASLOW VP PAYER STRATEGIES AS OF 8/1/22 19.00 36.00 X 0 330341 27425 DIANE HAMMON VP CHIEF STRATEGY OFFICER 55.00 0.00 X 469988 0 -115720 JARETT RIEGER VP CHIEF INNOV OFF. AS OF 10/30/22 55.00 0.00 X 291708 0 60008 L DAVID DE LA PARTE EVP GEN COUNS & ASST SEC 22.00 37.00 X 674699 0 -330860 TERRENCE WRIGHT VP-FAC & SUP SVCS 30.00 25.00 X 294403 0 45739 CHARLES FLETCHER VP DEPUTY GENERAL COUNSEL 55.00 2.00 X 331318 0 11043 LYNN MOSCINSKI FRM CHIEF ACADEMIC OFFICER 0.00 50.00 X 0 486755 -156195 SANTOSH MOHAN VP-DIGITAL TO 6/13/23 55.00 0.00 X 359488 0 -45357 KEN KOMORNY VP CHIEF PHARM OFFICER AS OF 9/4/22 30.00 25.00 X 0 271110 38704 JASON LEBSACK VP-CLINICAL TRIALS & OPS EXCELLENCE 55.00 0.00 X 283873 0 -4368 MARIANA BUGALLO-MUROS FRM VP CHIEF HR OFFICER 0.00 0.00 X 413408 0 -156962 LYNN ANSLEY VP-REVENUE CYCLE MANAGEMENT 55.00 0.00 X 213793 29025 -4609 CATHY GRANT VP CHIEF DIVERSITY EQUITY INCLUSION 55.00 0.00 X 250328 0 -38322 ANNA GIULIANO DIRECTOR CENTER OF EXCELLENCE 50.00 0.00 X 427541 0 -220177 DANA E ROLLISON VP CHIEF DATA OFFICER 55.00 0.00 X 420929 0 -212620 B LEE GREEN VP DIV, PR & STRAT COMM TO 8/6/22 55.00 0.00 X 362618 0 -167283 JOYCE OH VP INFO TECH & CIO AS OF 9/26/22 55.00 0.00 X 180913 0 10682 WJ WILSON VP GOVT RELATIONS 55.00 0.00 X 376519 0 -321681 TIMOTHY J ADAMS DIRECTOR, CHAIR 1.00 1.00 X X 0 0 0 BETH A HOUGHTON DIRECTOR, VICE CHAIR 1.00 1.00 X X 0 0 0 BENJAMIN H HILL III ESQ DIRECTOR, SECRETARY/TREASURER 1.00 1.00 X X 0 0 0 ALAN LEVINE DIRECTOR 1.00 0.00 X 0 0 0 ALLISON ADAMS DIRECTOR 1.00 0.00 X 0 0 0 ANGELA BIEVER DIRECTOR 1.00 0.00 X 0 0 0 CARLOS ALFONSO DIRECTOR 1.00 0.00 X 0 0 0 CECELIA FERMAN DIRECTOR TO 2/1/23 1.00 0.00 X 0 0 0 EDISON LIU DIRECTOR AS OF 8/1/22 1.00 1.00 X 0 0 0 EDWARD C DROSTE DIRECTOR 1.00 1.00 X 0 0 0 EDWARD DEBARTOLO DIRECTOR 1.00 0.00 X 0 0 0 FRANCISCO SANCHEZ DIRECTOR 1.00 0.00 X 0 0 0 GEOFFREY M DUYK PHD MD DIRECTOR 1.00 1.00 X 0 0 0 JESSICA COSTELLO DIRECTOR AS OF 2/1/23 1.00 0.00 X 0 0 0 JOHN RAMIL DIRECTOR 1.00 0.00 X 0 0 0 JOHN TOMLIN DIRECTOR 1.00 0.00 X 0 0 0 JOSEPH CABALLERO DIRECTOR 1.00 2.00 X 0 0 0 LIZ SMITH DIRECTOR 1.00 0.00 X 0 0 0 PAMELA STEWART DIRECTOR 1.00 0.00 X 0 0 0 REGINALD GOINS DIRECTOR 1.00 1.00 X 0 0 0 RHEA LAW DIRECTOR 1.00 0.00 X 0 0 0 ROSE BAKER REILLY DIRECTOR AS OF 8/1/22 1.00 1.00 X 0 0 0 THE HON CARL CARPENTER DIRECTOR 1.00 0.00 X 0 0 0 THE HON H LEE MOFFITT ESQ DIRECTOR 1.00 2.00 X 0 0 0 THE HON JAMES T HARGRETT ESQ DIRECTOR 1.00 0.00 X 0 0 0 THE HON JOHN A GRANT ESQ DIRECTOR 1.00 0.00 X 0 0 0 VALERIE GODDARD DIRECTOR 1.00 1.00 X 0 0 0 VALERIE MONTGOMERY RICE DIRECTOR 1.00 0.00 X 0 0 0 13128183 2668020 -2066814 600 1 1 0 BARR & BARR INC 460 W 34TH ST FL 10 NEW YORK NY 10001 PROFESSIONAL SERVICES 84256752 BIRDSALL VOSS & ASSOCIATES INC 250 W COVENTRY COURT STE 300 MILWAUKEE WI 53217 MARKETING SERVICES 9815422 MODUS DIRECT LLC 1343 MAIN ST STE 600 SARASOTA FL 34236 MARKETING SERVICES 3108700 EVERCOMMERCE SOLUTIONS INC 3601 WALNUT STREET STE 400 DENVER CO 80205 MARKETING SERVICES 2696793 E&B PARKING SERVICES INC ONE PARK PLACE STE 200 ANNAPOLIS MD 21401 TRANSPORTATION SERVICES 2648005 115 41035145 135699115 46971433 8568260 223705693 CELL THERAPY PRODUCTS 541700 10035288 1137680 8897608 MANAGEMENT SERVICES 541610 6081067 6081067 CORE LAB REVENUE 541900 5183750 5183750 0 RESEARCH COLLABORATION 541700 429792 429792 0 CONFERENCE REVENUE 541700 49900 49900 58242 58242 21838039 13857947 -262086 14120033 664103 664103 577067 100 576967 576967 142161 434806 294590414 52355280 302735767 0 -8145353 52355280 44209927 44209927 BOND CLOSING PROCEEDS 900099 2346908 2346908 LICENSE FEES 900099 1101075 1101075 PARKING 900099 992164 992164 757905 757905 5198052 310050728 7523467 14858750 63962818 X 687525 687525 63242 63242 12488679 10262322 2226357 388 319 69 146114643 103940118 42174525 7335302 5309421 2025881 14356930 11520683 2836247 9470680 6607197 2863483 2886378 2886378 64112 64112 138638 138638 1307579 1307579 21566944 16544829 5022115 6618669 2729153 3889516 22931767 16849184 6082583 11845569 297557 11548012 4592968 60305 4532663 2069903 1324734 745169 1758888 1758888 10769962 10769962 658943 20585 638358 INCOME TAX EXPENSE 2245849 0 2245849 ALLOCATION OF INTERCOMP 0 23464359 -23464359 MEDICAL SUPPLIES 12615501 6420347 6195154 RECRUITMENT 1690237 396825 1293412 7444216 3454240 3989976 301723512 209952945 91770567 0 413726823 155843806 230662713 684880809 22127438 24992183 17295405 27930120 1567136375 572367232 792738233 994769143 261213065 372004110 17200000 30740000 123978877 128852747 1878942555 2420012918 177165326 177580502 964504 3956594 667459257 984150028 31372456 24514063 876961544 1190201187 X 912956824 1129464847 89024187 100346884 1001981011 1229811731 1878942555 2420012918 X 8327216 38879233 180624271 X 0 1 X 1 1 1 X 161127950 180471501 175685146 197374169 223705693 938364459 161127950 180471501 175685146 197374169 223705693 938364459 938364459 6650393 6162666 5483559 6254190 14956856 39507664 6715669 10846860 14952638 8804380 8468496 49788043 4037784 2314119 2743929 2538246 5198052 16832130 1044492296 37165031 0.89840 0.88340 X SCHEDULE A, PART II, LINE 10, EXPLANATION OF OTHER INCOME: LICENSE FEES - 2018 AMOUNT: $ 2,496,454. 2019 AMOUNT: $ 291,471. 2020 AMOUNT: $ 1,307,836. 2021 AMOUNT: $ 915,644. 2022 AMOUNT: $ 1,101,075. PARKING - 2018 AMOUNT: $ 950,775. 2019 AMOUNT: $ 889,946. 2020 AMOUNT: $ 752,340. 2021 AMOUNT: $ 1,004,791. 2022 AMOUNT: $ 992,164. EYE INSTITUTE REIMBURSEMENT - 2018 AMOUNT: $ 36,832. LEASES - 2018 AMOUNT: $ 66,885. 2019 AMOUNT: $ 32,016. 2020 AMOUNT: $ 76,012. 2021 AMOUNT: $ 25,894. 2022 AMOUNT: $ 15,912. STAFF RETAIL SERVICES - 2018 AMOUNT: $ 45,748. 2019 AMOUNT: $ 33,888. 2020 AMOUNT: $ 23,681. 2021 AMOUNT: $ 56,458. 2022 AMOUNT: $ 29,857. GIFT SHOP - 2022 AMOUNT: $ 51,138. SUPPORT ACCOUNTS - 2018 AMOUNT: $ 179,614. 2019 AMOUNT: $ 758,853. REBATES/REFUNDS - 2018 AMOUNT: $ 247,557. 2019 AMOUNT: $ 171,326. 2020 AMOUNT: $ 161,862. 2021 AMOUNT: $ 342,083. 2022 AMOUNT: $ 414,397. MISC - 2018 AMOUNT: $ 13,919. 2019 AMOUNT: $ 11,786. 2020 AMOUNT: $ 21,788. 2021 AMOUNT: $ 19,262. 2022 AMOUNT: $ 8,544. REIMBURSEMENT OF EXPENSES - 2019 AMOUNT: $ 55,568. 2020 AMOUNT: $ 116,640. 2021 AMOUNT: $ 111,395. 2022 AMOUNT: $ 148,730. PATENT EXPENSE REIMBURSEMENT - 2019 AMOUNT: $ 69,265. 2020 AMOUNT: $ 67,484. 2021 AMOUNT: $ 62,719. 2022 AMOUNT: $ 89,327. UNCLAIMED PROPERTY - 2020 AMOUNT: $ 216,286. BOND CLOSING PROCEEDS - 2022 AMOUNT: $ 2,346,908. RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 1 1 0 1 4037 1 5547 0 1 203079 1 8288 1 13915 234866 0 PART II-B, LINE 1: THE H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE, INC. AND ITS FIVE NON-PROFIT SUBSIDIARY CORPORATIONS ("CORPORATION") WERE CREATED TO GOVERN AND OPERATE THE H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE ("INSTITUTE") PURSUANT TO SECTION 1004.43, FLORIDA STATUTES. AMONG OTHER THINGS, SECTION 1004.43, FLORIDA STATUTES PROVIDES: (1) THAT THE CORPORATION SHALL ENTER INTO AN AGREEMENT WITH THE STATE BOARD OF EDUCATION FOR THE UTILIZATION OF FACILITIES ON THE CAMPUS OF THE UNIVERSITY OF SOUTH FLORIDA; (2) THAT THE CORPORATION SUBMIT ANNUAL POST AUDITS OF ITS FINANCIAL ACCOUNTS TO THE AUDITOR GENERAL OF THE STATE OF FLORIDA AND THE BOARD OF GOVERNORS FOR THEIR REVIEW; AND (3) THAT THE CORPORATION'S CEO REPORT TO THE BOARD OF GOVERNORS OR ITS DESIGNEE AND PROVIDE COPIES OF THE INSTITUTE'S ANNUAL REPORT TO THE GOVERNOR OF THE STATE OF FLORIDA, THE CABINET, THE PRESIDENT OF THE SENATE, THE SPEAKER OF THE HOUSE AND THE CHAIR OF THE BOARD OF GOVERNORS. ALTHOUGH THE CORPORATION IS A PRIVATE ENTITY, IT IS NONETHELESS SUBJECT TO THE STATE OF FLORIDA'S PUBLIC RECORDS AND THE PUBLIC MEETINGS LAWS. THE CORPORATION ALSO RELIES ON ANNUAL APPROPRIATIONS BY THE LEGISLATURE OF THE STATE OF FLORIDA AND GRANTS FROM VARIOUS LOCAL, STATE AND FEDERAL AGENCIES FOR OPERATION AND MAINTENANCE OF ITS FACILITIES AND FOR SPECIFIC RESEARCH AND CLINICAL PROGRAMS. FOR THESE REASONS, THE CORPORATION FROM TIME TO TIME ENGAGES LOBBYISTS AND OTHER CONSULTANTS; (1) TO ASSIST IT IN COMPLYING WITH ITS REPORTING REQUIREMENTS TO THE STATE OF FLORIDA UNDER SECTION 1004.43, FLORIDA STATUTES; (2) TO MONITOR LEGISLATIVE AND EXECUTIVE BRANCH ACTION AT LOCAL, STATE AND FEDERAL LEVELS OF GOVERNMENT WHICH IMPACT ITS OPERATION AND THE FULFILLMENT OF ITS MISSION; AND (3) TO INFLUENCE LEGISLATION IN FURTHERANCE OF ITS MISSION IN THE AREAS OF CANCER RESEARCH AND TREATMENT, THE TEACHING AND TRAINING OF HEALTH CARE PROFESSIONALS AND COMMUNITY EDUCATION AND OUTREACH ACTIVITIES. THE CORPORATION DOES NOT ENGAGE IN ANY ACTIVITIES TO SUPPORT OR OPPOSE ANY CANDIDATE FOR PUBLIC OFFICE. PART II-B, LINE 1I, OTHER ACTIVITIES THE OTHER ACTIVITIES AMOUNT LISTED ON LINE 1I IS COMPRISED OF EXPENSES RELATED TO ORCHESTRATING CONTACT BETWEEN GRASSROOTS SUPPORTERS (WHO ARE VOLUNTEERS) AND ELECTED OFFICIALS TO PROMOTE THE INSTITUTION'S LEGISLATIVE OBJECTIVES. 22187330 22187330 678237697 290326061 387911636 3136748 3133146 3602 423443996 278908025 144535971 440130604 440130604 994769143 INTEREST IN NET ASSETS OF FOUNDATION 68741551 RECEIVABLES FROM CONTROLLED ORGS 10640088 OTHER RECEIVABLES 12014628 RIGHT OF USE ASSET-OPERATING 37456480 128852747 LEASE OBLIGATIONS 23993392 OTHER LIABILITIES 520671 24514063 X PART X, LINE 2: H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE, INC. DID NOT HAVE ANY UNCERTAIN POSITIONS IN ITS AUDITED FINANCIAL STATEMENTS. THE ASC-740 FOOTNOTE READS AS FOLLOWS: SIGNIFICANT JUDGMENT IS REQUIRED TO EVALUATE UNCERTAIN TAX POSITIONS. THE CANCER CENTER EVALUATES ITS UNCERTAIN TAX POSITIONS ON A REGULAR BASIS. ITS EVALUATIONS ARE BASED ON A NUMBER OF FACTORS, INCLUDING CHANGES IN FACTS AND CIRCUMSTANCES, CHANGES IN TAX LAW, AND CORRESPONDENCE WITH TAX AUTHORITIES. THE CANCER CENTER ACCOUNTS FOR UNCERTAIN TAX POSITIONS BY RECOGNIZING A TAX BENEFIT OR LIABILITY AT THE LARGEST AMOUNT THAT, IN ITS JUDGMENT, IS MORE THAN 50% LIKELY TO BE REALIZED OR PAID BASED UPON TECHNICAL MERITS OF THE POSITION. THE CANCER CENTER CURRENTLY HAS NO TAX BENEFITS OR LIABILITIES RELATED TO UNCERTAIN TAX POSITIONS. 1 SOUTH ASIA 0 1 MAINTAINING OFFICES, EMPLOYEES OR AGENTS 96421 SUB-SAHARAN AFRICA 0 1 PROGRAM SERVICES TRAINING & RESEARCH 30131 SUB-SAHARAN AFRICA - ANGOLA, BENIN, BOTSWANA, BURKINA FASO, 0 1 GRANTMAKING 63242 CENTRAL AMERICA AND THE CARIBBEAN 0 0 INVESTMENT 1531664 0 3 0 0 0 3 1721458 0 1721458 SUB-SAHARAN AFRICA TRAINING & RESEARCH COLLABORATION WITH UNIVERSITY OF GHANA 63242 CASH PAYMENT 0 1 0 1 0 0 1 0 0 PART I, LINE 2: MOFFITT'S PRINCIPAL INVESTIGATOR WORKS IN CONJUNCTION WITH THE RESEARCH FINANCE DEPARTMENT TO MONITOR THE ACTIVITIES OF FOREIGN SUBRECIPIENTS AS NECESSARY TO ENSURE THAT SUBAWARDS ARE USED FOR AUTHORIZED PURPOSES, IN COMPLIANCE WITH FEDERAL STATUTES, REGULATIONS, AND THE TERMS AND CONDITIONS OF THE SUBAWARD; AND THAT SUBAWARD PERFORMANCE GOALS ARE ACHIEVED. MONITORING PROCEDURES INCLUDE REVIEWING FINANCIAL AND PERFORMANCE REPORTS, ENSURING THAT THE FOREIGN SUBRECIPIENT TAKES TIMELY AND APPROPRIATE ACTION ON ANY DEFICIENCIES, AND ISSUING A MANAGEMENT DECISION LETTER FOR GRANT AUDIT FINDINGS TO THE SUBRECIPIENT. DEPENDING ON THE RESULTS OF THE RISK ANALYSIS OF THE SUBRECIPIENT, ADDITIONAL MONITORING TOOLS MAY INCLUDE PROVIDING TRAINING AND TECHNICAL ASSISTANCE ON PROGRAM-RELATED MATTERS, PERFORMING ON-SITE REVIEWS OF THE PROGRAM'S OPERATIONS, ARRANGING FOR AGREED-UPON PROCEDURES ENGAGEMENTS AND AUDITS WHEN FUNDS EXPENDED EQUAL OR EXCEED CERTAIN THRESHOLDS, AND TAKING CORRECTIVE ACTION AGAINST NONCOMPLIANT SUBRECIPIENTS. PART I, LINE 3: ACCRUAL METHOD OF ACCOUNTING WAS USED TO ACCOUNT FOR EXPENDITURES ON SCHEDULE F CONSISTENT WITH THE AUDITED FINANCIAL STATEMENTS. PART III ACCOUNTING METHOD: 1 H LEE MOFFITT CANCER CENTER & RESEARCH INSTITUTE HOSPITAL INC 12902 MAGNOLIA DRIVE TAMPA FL 33612 593238634 501C3 398225 0 INTERCOMPANY SUPPORT LEUKEMIA SOC OF AMERICA 3505 E FRONTAGE RD STE 145 TAMPA FL 33607 135644916 501C3 75000 0 SPONSORSHIP KEEP HILLSBOROUGH MOVING INC 610 S BOULEVARD TAMPA FL 33606 830867146 501C4 25000 0 SPONSORSHIP AMERICAN CANCER SOCIETY INC 12810 USF MAGNOLIA DR TAMPA FL 33612 131788491 501C3 20000 0 SPONSORSHIP KAY YOW CANCER FUND 2474 WALNUT ST PMB 331 CARY NC 27518 261789695 501C3 15000 0 SPONSORSHIP BEST ACADEMY 10006 CROSS CREEK BLVD TAMPA FL 33647 202834380 501C3 15000 0 SPONSORSHIP THE POYNTER INSTITUTE 801 THIRD STREET SOUTH ST PETERSBURG FL 33701 591630423 501C3 10000 0 SPONSORSHIP TAMPA ORG OF BLACK AFFAIRS 11266 W HILLSBOROUGH AVE STE 328 TAMPA FL 33635 592468415 501C4 10000 0 SPONSORSHIP TAMPA ALUMNI CHAPTER KAPPA ALPHA PSI FRATERNITY INC PO BOX 5062 TAMPA FL 33675 261201574 501C7 10000 0 SPONSORSHIP USF FOUNDATION 4202 E FOWLER AVE ALC 100 TAMPA FL 33620 590879015 501C3 10000 0 SPONSORSHIP GREATER TAMPA CHAMBER COMMERCE 201 N FRANKLIN ST STE 201 TAMPA FL 33602 590474960 501C6 8000 0 SPONSORSHIP BIOFLORIDA INC 6742 FOREST HILL BLVD STE 256 WEST PALM BEACH FL 33413 593436638 501C6 5500 0 SPONSORSHIP AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC 250 WILLIAMS ST ATLANTA GA 30303 522340031 501C4 5350 0 SPONSORSHIP 7 6 PART I, LINE 2: THE SCHEDULE I, PART II, GRANTS LISTED AS SPONSORSHIPS ARE APPROVED THROUGH THE CHECK REQUEST PROCESS. BECAUSE OF THE NATURE OF THE GRANTS, THE GRANT USE IS NOT MONITORED SINCE THEY ARE GIVEN TO THE ORGANIZATION FOR A SPECIFIC PURPOSE OR EVENT. THE GRANTS LISTED AS INTERCOMPANY SUPPORT ARE ONLY MADE TO RELATED ORGANIZATIONS TO SUPPORT THEIR OPERATIONS. X 0 1 X X X X 1 1 0 0 0 1 1 0 0 PATRICK HWU PRES/CEO 1142684 0 610 0 18297 0 101682 0 3941 0 1267214 0 0 0 JOHN CLEVELAND EVP-CENTER DIRECTOR & CHIEF SCI OFF. 645023 0 0 0 212631 0 -117710 0 38606 0 778550 0 0 0 SARABDEEP SINGH EVP COO 614018 0 0 0 4902 0 57658 0 36171 0 712749 0 0 0 EDMONDO ROBINSON SVP CHIEF DIGITAL OFFICER 574363 0 52309 0 1710 0 38696 0 35221 0 702299 0 0 0 G DOUGLAS LETSON EVP-PIC 0 757687 0 4510 0 76355 0 -266587 0 26089 0 598054 0 0 JAMES J MULAY ACD TRANSLATIONAL RSCH 475477 0 43292 0 52250 0 -19219 0 27425 0 579225 0 0 0 JONATHAN ZAGER CHIEF ACADEMIC OFFICER 0 609825 0 98290 0 4122 0 -204949 0 36472 0 543760 0 0 YVETTE M LYONS TREMONTI EVP-CFAO & ASST TREASURER 740894 0 0 0 83376 0 -379274 0 36971 0 481967 0 0 0 ELSA FLORES ACD BASIC SCIENCE 327858 0 49154 0 6504 0 39504 0 30666 0 453686 0 0 0 RANDA M PERKINS CHIEF MEDICAL INFO OFFICER 411051 0 31615 0 4339 0 -31593 0 26359 0 441771 0 0 0 SHELLEY TWOROGER ACD POPULATION SCIENCE 335603 0 30536 0 1119 0 42274 0 14821 0 424353 0 0 0 BRIAN SPRINGER VP RESEARCH ADMINISTRATION 377103 0 34662 0 1990 0 -50137 0 33693 0 397311 0 0 0 HENRY REYES VP-PARTNERSHIP DEVELOPMENT 307896 0 28353 0 4601 0 24337 0 26497 0 391684 0 0 0 DONALD FUTRELL VP PLAN, DESIGN & CONS 302094 0 28288 0 20974 0 4586 0 30801 0 386743 0 0 0 AMY DURHAM VP-HUMAN RECOURCES OPS 320453 0 17234 0 24558 0 -10144 0 33353 0 385454 0 0 0 JOANNA WEISS SVP FINANCE 385948 0 35662 0 27226 0 -123119 0 36156 0 361873 0 0 0 EVAN ZASLOW VP PAYER STRATEGIES AS OF 8/1/22 0 241023 0 38791 0 50527 0 -423 0 30219 0 360137 0 0 DIANE HAMMON VP CHIEF STRATEGY OFFICER 406492 0 37371 0 26125 0 -146594 0 36211 0 359605 0 0 0 JARETT RIEGER VP CHIEF INNOV OFF. AS OF 10/30/22 236563 0 11025 0 44120 0 26384 0 35220 0 353312 0 0 0 L DAVID DE LA PARTE EVP GEN COUNS & ASST SEC 617340 0 595 0 56764 0 -356164 0 28652 0 347187 0 0 0 TERRENCE WRIGHT VP-FAC & SUP SVCS 266214 0 24300 0 3889 0 27153 0 24534 0 346090 0 0 0 CHARLES FLETCHER VP DEPUTY GENERAL COUNSEL 301695 0 28039 0 1584 0 -21830 0 35654 0 345142 0 0 0 LYNN MOSCINSKI FRM CHIEF ACADEMIC OFFICER 0 439730 0 23420 0 23605 0 -181840 0 28993 0 333908 0 0 SANTOSH MOHAN VP-DIGITAL TO 6/13/23 328205 0 30602 0 681 0 -71866 0 30111 0 317733 0 0 0 KEN KOMORNY VP CHIEF PHARM OFFICER AS OF 9/4/22 0 240075 0 11163 0 19872 0 6586 0 33754 0 311450 0 0 JASON LEBSACK VP-CLINICAL TRIALS & OPS EXCELLENCE 245362 0 15748 0 22763 0 -25764 0 23901 0 282010 0 0 0 MARIANA BUGALLO-MUROS FRM VP CHIEF HR OFFICER 46282 0 0 0 367126 0 -159670 0 3624 0 257362 0 0 0 LYNN ANSLEY VP-REVENUE CYCLE MANAGEMENT 196310 28968 14857 0 2626 57 -36128 805 26650 6166 204315 35996 0 0 CATHY GRANT VP CHIEF DIVERSITY EQUITY INCLUSION 214700 0 13668 0 21960 0 -70761 0 34848 0 214415 0 0 0 ANNA GIULIANO DIRECTOR CENTER OF EXCELLENCE 379952 0 38700 0 8889 0 -251051 0 36331 0 212821 0 0 0 DANA E ROLLISON VP CHIEF DATA OFFICER 363086 0 33011 0 24832 0 -231927 0 23287 0 212289 0 0 0 B LEE GREEN VP DIV, PR & STRAT COMM TO 8/6/22 311460 0 26831 0 24327 0 -192327 0 29654 0 199945 0 0 0 JOYCE OH VP INFO TECH & CIO AS OF 9/26/22 95545 0 35000 0 50368 0 36 0 11709 0 192658 0 0 0 PART I, LINE 1A INSTITUTE PAYS MEMBERSHIP DUES TO A SOCIAL CLUB FOR PATRICK HWU, DAVID DE LA PARTE AND W.J. WILSON. THE AMOUNT PAID IS SUBSEQUENTLY ADDED TO TAXABLE WAGES FOR THE RESPECTIVE INDIVIDUAL. PART I, LINE 1B: PAYMENTS MADE FOR SOCIAL CLUB DUES ARE INITIALLY APPROVED BY EXECUTIVE LEADERSHIP AND HUMAN RESOURCES AND REVIEWED/APPROVED BY THE JOINT EXECUTIVE COMPENSATION AND BENEFITS COMMITTEE (JE&BC), APPOINTED BY THE BOARD TO APPROVE SUCH PAYMENTS AND ASSOCIATED AMOUNTS. PART I, LINES 4A-B MARIANA BUGALLO-MUROS, A FORMER OFFICER, RECEIVED SEVERANCE PAYMENTS TOTALLING $366,178 IN TAX YEAR 2022. TO BE ELIGIBLE TO PARTICIPATE IN THE 457(F) NON-QUALIFIED SUPPLEMENTAL EXECUTIVE RETIREMENT PLAN (SERP), PARTICIPANTS MUST ELECT TO CONTRIBUTE AT LEAST 10% ACROSS THE 403(B) AND 457(B) PLANS, AND ARE VESTED AFTER 10 YEARS OF SERVICE. LUMP SUM DISTRIBUTIONS FROM THE ACCOUNT ARE MADE UPON NORMAL RETIREMENT OR TERMINATION. BELOW ARE INDIVIDUALS LISTED ON MOFFITT'S 2022 FORM 990 PART VII, SECTION A, THAT PARTICIPATED IN THE 457(F) SUPPLEMENTAL EXECUTIVE RETIREMENT PLAN AND THEIR RESPECTIVE AMOUNTS OF COMPENSATION CONSTRUCTIVELY RECEIVED IN TAX YEAR 2022 FROM THE PLAN: ANNA R. GIULIANO - $1,500 BERNARD L. GREEN - $19,258 BRIAN C. SPRINGER - $0 CHARLES R. FLETCHER - $0 DANA E. ROLLISON - $23,271 DIANE K. HAMMON - $22,095 DONALD E. FUTRELL - $15,503 EDMONDO J. ROBINSON - $0 ELSA FLORES - $4,750 G D. LETSON - $61,034 HENRY REYES - $0 JAMES J. MULAY - $38,383 JASON LEBSACK - $0 JOANNA WEISS - $25,889 JOHN L. CLEVELAND - $198,153 JONATHAN S. ZAGER - $1,500 KEN, KOMORNY - $0 LOUIS D. DE LA PARTE - $47,390 LYNN C. MOSCINSKI - $1,500 MARIANA BUGALLO-MUROS - $0 PATRICK HWU - $0 RANDA M. PERKINS - $3,385 SARABDEEP SINGH - $0 SANTOSH MOHAN - $0 SHELLEY S. TWOROGER - $0 TERRENCE WRIGHT - $0 W. J. WILSON - $14,682 YVETTE M. LYONS TREMONTI - $78,474 PART I, LINE 6 IN GENERAL, INCENTIVE COMPENSATION IS BASED ON A PERCENTAGE OF MOFFITT'S NET OPERATING INCOME AND ACHIEVEMENT AGAINST SPECIFIC ORGANIZATIONAL GOALS, DIVISIONAL AND/OR INDIVIDUAL GOALS, PROVIDED A CERTAIN NET OPERATING INCOME THRESHOLD IS MET. SCHEDULE J COLUMN C THE AMOUNT OF RETIREMENT AND DEFERRED COMPENSATION FOR CERTAIN EXECUTIVES IN SCHEDULE J, COLUMN (C) INCLUDES A DECREASE IN ACTUARIAL VALUE OF THE DEFINED BENEFIT PLAN THAT OCCURRED DURING THE YEAR. A CITY OF TAMPA 591101138 875146AQ5 2016-11-16 58742390 SEE SUPPLEMENTAL SCH K PART VI 0 0 0 B CITY OF TAMPA 591101138 875161CE9 2016-11-03 93832926 SEE SUPPLEMENTAL SCH K PART VI 0 0 0 C CITY OF TAMPA 591101138 875146BD3 2020-06-25 119978935 SEE SUPPLEMENTAL SCH K PART VI 0 0 0 D CITY OF TAMPA 591101138 875161DD0 2020-06-25 302148464 SEE SUPPLEMENTAL SCH K PART VI 0 0 0 A 12475000 60891106 594871 59377759 18519 899957 2019 0 0 1 1 B 11750000 93842533 92781244 1061289 2010 1 0 1 1 C 120347649 1084744 119247704 15201 2023 0 0 1 1 D 2270000 304240859 1882947 293595863 8762049 2023 0 0 1 1 A 0 0 0 0 0 0 1 B 0 0 0 0 0 0 1 C 0 0 0 0 0 0 1 D 0 0 0 0 0 0 1 A 0 0 0 1 0 0 0 0 1 B 0 0 0 1 0 0 0 0 1 C 0 1 0 1 0 0 1 THE TORONTO DOMINION BANK 1.750000000000 1 0 1 D 0 1 0 1 0 0 1 THE TORONTO DOMINION BANK 1.750000000000 1 0 1 A 1 B 1 C 1 D 1 DATE REBATE COMPUTATION PERFORMED ISSUER NAME: CITY OF TAMPA DATE THE REBATE COMPUTATION WAS PERFORMED: 06/30/2023 ISSUER NAME: CITY OF TAMPA DATE THE REBATE COMPUTATION WAS PERFORMED: 07/01/2023 ISSUER NAME: CITY OF TAMPA DATE THE REBATE COMPUTATION WAS PERFORMED: 06/30/2023 ISSUER NAME: CITY OF TAMPA DATE THE REBATE COMPUTATION WAS PERFORMED: 06/30/2023 ISSUER NAME: PASCO COUNTY FLORIDA DATE THE REBATE COMPUTATION WAS PERFORMED: 06/30/2023 FORM 990, SCHEDULE K, PART IA COLUMN (F) PROCEEDS OF THE 2016A BOND ISSUANCE WERE USED TO PURCHASE LAND AND BUILDING ON USF CAMPUS AND AN ADDITIONAL MCKINLEY CAMPUS SITE FOR CONSTRUCTION OF RESEARCH AND RESEARCH SUPPORT FACILITIES, CLINICAL AND RESEARCH SUPPORT OFFICES, THE RELOCATION OF CHILD DEVELOPMENT CENTER, AND THE CONSTRUCTION OF RESEARCH LABS. FORM 990, SCHEDULE K, PART IB COLUMN (F) SERIES 2016B IS AN ADVANCE REFUNDING ON SERIES 2007A WHICH WAS USED TO: 1) FINANCE THE COST OF CONSTRUCTION AND EQUIPPING A FOUR STORY ADDITION TO THE MAIN CAMPUS OF THE HOSPITAL, TO INCLUDE 36 ADDITIONAL INPATIENT BEDS, RADIATION ONCOLOGY CLINIC PROGRAM EXPANSION WITH THE ADDITION OF TWO NEW VAULTS USED FOR STATE OF THE ART LINEAR ACCELERATORS, CLINICAL LAB AND PATHOLGY PROGRAM EXPANSION, APPROXIMATELY 40,000 GROSS SQUARE FEET OF FACULTY OFFICE SPACE, AND 1,000 SPACE PARKING GARAGE. 2) FINANCE THE COST OF VARIOUS BACKFILL AND REFURBISHMENT PROJECTS, INCLUDING THE ADDITION OF EIGHT INPATIENT BEDS IN EXISTING SPACE LOCATED AT THE INSTITUTE AND HOSPITAL. FORM 990, SCHEDULE K, PART IC COLUMN (F) PROCEEDS FROM THE 2020A (IN ADDITION TO THE 2020B) BONDS WERE USED FOR: 1) ACQUISITION, CONSTRUCTION, FURNISHING AND EQUIPPING OF VARIOUS MEDICAL AND RESEARCH FACILITIES CAPITAL PROJECTS INCLUDING HOSPITAL EXPANSION PROJECT. 2)VARIOUS FACILITIES, INFRASTRUCTURE SUPPORT, EQUIPMENT, FURNISHINGS, BACKFILL AND REFURBISHMENT PROJECTS. FORM 990, SCHEDULE K, PART ID COLUMN (F) PROCEEDS FROM THE 2020B (IN ADDITION TO 2020A) BONDS WERE USED FOR: 1) ACQUISITION, CONSTRUCTION, FURNISHING AND EQUIPPING OF VARIOUS MEDICAL AND RESEARCH FACILITIES CAPITAL PROJECTS INCLUDING HOSPITAL EXPANSION PROJECT. 2)VARIOUS FACILITIES, INFRASTRUCTURE SUPPORT, EQUIPMENT, FURNISHINGS, BACKFILL AND REFURBISHMENT PROJECTS. FORM 990, SCHEDULE K, PART IE COLUMN (F) PROCEEDS FROM THE 2022A (IN ADDITION TO 2022B) BONDS WERE: 1) DEPOSITED IN AN ESCROW FUND TO CURRENTLY REFUND AND REDEEM THE 2012A REFUNDED BONDS ON SEPTEMBER 1, 2022. 2) COST OF ISSUANCE OF THE SERIES 2022A BONDS. FORM 990, SCHEDULE K, PART IF COLUMN (F) PROCEEDS FROM THE 2022B (IN ADDITION TO 2022A) BONDS WERE: 1) DEPOSITED IN AN ESCROW FUND TO CURRENTLY REFUND AND REDEEM THE 2012B REFUNDED BONDS ON JULY 1, 2022. 2) COST OF ISSUANCE OF THE SERIES 2022B BONDS. FORM 990, SCHEDULE K, PART IG COLUMN (F) PROCEEDS FROM THE 2023A BONDS WILL BE USED FOR: FINANCING OR REFINANCING, INCLUDING THROUGH REIMBURSEMENT, THE ACQUISITION, DEVELOPMENT, CONSTRUCTION, EQUIPPING, FURNISHING AND IMPROVEMENT OF VARIOUS MEDICAL AND RESEARCH FACILITIES, INCLUDING, WITHOUT LIMITATION, ONE OR MORE RESEARCH BUILDINGS, PROTON THERAPY CENTERS, MOFFITT AMBULATORY CLINICS, AND OTHER CAPITAL EXPENSES ASSOCIATED WITH THE SPEROS FL PROJECT IN PASCO COUNTY, FLORIDA. FORM 990, SCHEDULE K, PART II THE DIFFERENCE BETWEEN THE ISSUE PRICE IN SCHEDULE K, PART I AND TOTAL PROCEEDS OF THE ISSUE IN PART II, LINE 3 FOR EACH ISSUE IS INVESTMENT EARNINGS. A HILLSBOROUGH CTY INDUSTRIAL DEV AUTHORITY 591293512 43232YBJ3 2022-06-06 88408325 SEE SUPPLEMENTAL SCH K PART VI 0 0 0 B HILLSBOROUGH CTY INDUSTRIAL DEV AUTHORITY 591293512 43233AFU5 2022-04-04 19500545 SEE SUPPLEMENTAL SCH K PART VI 0 0 0 C PASCO COUNTY FLORIDA 596000793 70252AAX3 2023-03-15 352942534 SEE SUPPLEMENTAL SCH K PART VI 0 0 0 A 88707044 88268912 438132 2016 1 0 1 1 B 19519049 19401546 117503 2022 1 0 1 1 C 356327841 1997958 4375100 3044311 346910472 2026 0 0 0 1 A 0 0 0 1 1 0.00500 0.00500 0 0 1 B 0 0 0 0 0 0 1 C 0 0 0 0 0 0 1 A 0 1 0 0 0 0 0 0 1 B 0 1 0 0 0 0 0 0 1 C 0 1 0 1 0 0 0 0 1 A 1 B 1 C 1 AVEMARIE BOBB-MORGAN FAMILY OF OFFICER, CATHY GRANT 77048 EMPLOYEE COMPENSATION 0 X EQUIPMENT 17 8568260 PURCHASE PRICE 0 0 0 0 PART I, COLUMN (B): THE NUMBER ON LINE 25(B) REPRESENTS THE NUMBER OF CONTRIBUTIONS, NOT THE NUMBER OF ITEMS CONTRIBUTED. FORM 990, PART VI, SECTION A, LINE 2 THE FOLLOWING DIRECTORS AND OFFICERS, THAT JOINTLY SERVE ON THE INSTITUTE AND A FOR-PROFIT RELATED ENTITY, QUALIFY AS HAVING A BUSINESS RELATIONSHIP. INSTITUTE & MOFFITT TECHNOLOGIES CORPORATION (MTC): LOUIS D. DE LA PARTE, OFFICER INSTITUTE & MTC OFFICER YVETTE M. LYONS TREMONTI, OFFICER INSTITUTE & MTC OFFICER PATRICK HWU, OFFICER INSTITUTE & MTC DIRECTOR JOHN CLEVELAND, OFFICER INSTITUTE & MTC DIRECTOR INSTITUTE & ONCOBAY CLINICAL (ONCOBAY): GEOFFREY M. DUYK, INSTITUTE DIRECTOR & ONCOBAY DIRECTOR LOUIS D. DE LA PARTE, INSTITUTE OFFICER & ONCOBAY DIRECTOR YVETTE M. LYONS TREMONTI, INSTITUTE OFFICER & ONCOBAY DIRECTOR IN ADDITION, THE FOLLOWING INDIVIDUALS HAVE INVESTED IN THE SAME COMPANIES IN WHICH MOFFITT DOES BUSINESS: 1) EDWARD DROSTE AND GEOFFREY DUYK HAVE INVESTED INDEPENDENTLY IN ANNUVIA PLANT NUTRIENTS HOLDINGS INC. 2) TIM ADAMS, JOSEPH CABALLERO AND CLAUDINE CABELLERO, JOSEPH'S WIFE, HAVE INVESTED INDEPENDENTLY IN LUMINA. FORM 990, PART VI, SECTION B, LINE 11B PRIOR TO ELECTRONICALLY FILING FORM 990 (RETURN OF ORGANIZATION EXEMPT FROM INCOME TAX), A COPY OF THE RETURN IS PROVIDED TO THE GOVERNING BODY, GIVING EACH BOARD MEMBER TIME TO REVIEW THE RETURN. BOARD MEMBERS HAVE THE OPPORTUNITY TO ASK QUESTIONS RELATED TO THE INFORMATION PROVIDED ON THE RETURN. MOFFITT'S FORM 990 IS ALSO PROVIDED TO THE CHIEF FINANCIAL OFFICER FOR REVIEW. BASED ON THE REVIEW ANY SUGGESTED COMMENTS OR CHANGES ARE DISCUSSED PRIOR TO SIGNING. FORM 990, PART VI, SECTION B, LINE 12C ON AN ANNUAL BASIS A PRESENTATION IS MADE TO RESEARCH BOARD MEMBERS TO REVIEW THE CONFLICT OF INTEREST POLICY AND PROCEDURES FOR DISCLOSING ANY POTENTIAL CONFLICTS. EACH DIRECTOR, OFFICER, COMMITTEE MEMBER, AND KEY EMPLOYEE SHALL COMPLETE A CONFLICT OF INTEREST DISCLOSURE CERTIFICATION VIA THE ELECTRONIC DISCLOSURE SYSTEM. ANY DIRECTOR, OFFICER, COMMITTEE MEMBER, OR KEY EMPLOYEE WHO REASONABLY BELIEVES THAT HE OR SHE MAY HAVE AN ACTUAL OR POTENTIAL CONFLICT OF INTEREST MUST DISCLOSE THE EXISTENCE OF AND THE MATERIAL FACTS OF THE NATURE OF HIS/HER INTEREST ON THE FORM. THE ELECTRONIC FORM IS SUBMITTED TO THE CORPORATE COMPLIANCE OFFICE, WHICH REVIEWS THE FORMS, GATHERS ADDITIONAL RELEVANT INFORMATION WHERE NECESSARY, AND PREPARES A SUMMARY OF THE DISCLOSURES TO BE REVIEWED BY THE CONFLICT OF INTEREST WORK GROUP. IF A DIRECTOR OR COMMITTEE MEMBER DISCLOSES THAT HE/SHE HAS A POTENTIAL CONFLICT OF INTEREST AT A BOARD OR COMMITTEE MEETING, SUCH DIRECTOR OR COMMITTEE MEMBER MUST DISCLOSE THE NATURE OF THE INTEREST AND ANY RELATED INFORMATION AND RESPOND TO QUESTIONS AS MAY BE REQUIRED BY THE REMAINING MEMBERS. BASED ON THE INFORMATION DISCLOSED, THE REMAINING BOARD MEMBERS WILL DETERMINE WHETHER A CONFLICT OF INTEREST EXISTS. IF A CONFLICT EXISTS THE BOARD OR COMMITTEE SHALL DETERMINE WHETHER AN ALTERNATIVE TRANSACTION OR ARRANGEMENT THAT WOULD NOT GIVE RISE TO A CONFLICT IS EQUALLY ADVANTAGEOUS. IF AN ALTERNATIVE TRANSACTION IS NOT EQUALLY ADVANTAGEOUS THE DIRECTOR OR COMMITTEE MEMBER WHO IS THE SUBJECT OF THE CONFLICT SHALL NOT VOTE ON, NOR USE HIS/HER PERSONAL INFLUENCE ON, NOR PARTICIPATE IN DISCUSSIONS OR DELIBERATIONS WITH RESPECT TO THE TRANSACTION. FORM 990, PART VI, SECTION B, LINE 15 MOFFITT'S BOARD OF DIRECTORS HAS AN ESTABLISHED SUB-COMMITTEE, THE JOINT EXECUTIVE COMPENSATION & BENEFITS COMMITTEE (JEC&BC) THAT IS MADE UP ENTIRELY OF INDEPENDENT, OUTSIDE DIRECTORS. THIS COMMITTEE IS CHARGED WITH THE OVERSIGHT OF THE PERFORMANCE AND COMPENSATION OF MOFFITT EXECUTIVES AND DISQUALIFIED PERSONS. THESE POSITIONS INCLUDE THE CEO, EXECUTIVE VICE PRESIDENTS, SENIOR VICE PRESIDENTS, VICE PRESIDENTS AND DEPARTMENT CHAIRPERSONS. TO ACCOMPLISH ITS MISSION, THE COMMITTEE CAN AS NEEDED AND DOES AT ITS DISCRETION, ENGAGE INDEPENDENT, OUTSIDE ADVISORS INCLUDING, BUT NOT LIMITED TO ATTORNEYS AND COMPENSATION CONSULTANTS. ON AN ANNUAL BASIS THE JEC&BC ENGAGES A NATIONALLY KNOWN, THIRD PARTY CONSULTING FIRM TO PROVIDE A DETAILED STUDY OF THE CASH COMPENSATION FOR EACH EXECUTIVE, DISQUALIFIED PERSON AND INDIVIDUAL IN KEY POSITIONS. THE CONSULTANT USES A VARIETY OF PUBLISHED SURVEYS COMPILED BY INDEPENDENT FIRMS TO PROVIDE THE SOURCE DATA FOR THE STUDY. USING FUNCTIONALLY COMPARABLE POSITIONS IN OTHER SIMILARLY SIZED, NOT-FOR-PROFIT AND FOR-PROFIT HEALTHCARE, ACADEMIC AND RESEARCH ORGANIZATIONS, THE CONSULTING FIRM PRODUCES A STUDY THAT COMPARES EACH DESIGNATED MOFFITT POSITION TO ITS APPROPRIATE MARKET EQUIVALENT. THE RESULTING DATA IS PROVIDED TO THE DIRECTOR OF COMPENSATION, WHO IS NOT INCLUDED IN THE EXECUTIVE OR DISQUALIFIED PERSON CATEGORIES, FOR USE IN THE FORMULATION OF RECOMMENDATIONS FOR COMPENSATION CHANGES TO MAINTAIN MARKET COMPETITIVENESS OR TO REWARD PERFORMANCE. THESE RECOMMENDATIONS ALONG WITH THE CONSULTANT'S COMPARABILITY DATA ARE PRESENTED TO THE JEC&BC FOR IT TO CONFIRM ITS REASONABLENESS, MAKE MODIFICATIONS AS IT DEEMS NECESSARY AND PROVIDE FINAL APPROVAL. EVERY THIRD YEAR THE INDEPENDENT CONSULTANT ANALYZES THE TOTAL EXECUTIVE COMPENSATION PROGRAM, USING THE SAME METHODOLOGY AS DESCRIBED ABOVE, THAT INCLUDES THE VALUE OF ALL BENEFITS AND PERQUISITES (CASH AND NON-CASH) PROVIDED AS COMPENSATION TO THE EXECUTIVES AND DISQUALIFIED PERSONS. THE PURPOSE OF THE ANALYSIS IS TO PROVIDE AN OPINION ON THE REASONABLENESS OF EACH OF THE INDIVIDUAL COMPENSATION COMPONENTS AND THE AGGREGATE COMPENSATION TOTAL. THIS MORE COMPREHENSIVE ANALYSIS IS PROVIDED TO THE JEC&BC FOR THEIR USE IN THE ANNUAL REVIEW PROCESS. MINUTES ARE KEPT AT EACH OF THESE ANNUAL MEETINGS DETAILING THE RECOMMENDATIONS PRESENTED AND THE DECISIONS MADE BY THE COMMITTEE. THESE MINUTES ARE PUBLISHED TO THE COMMITTEE AT THE NEXT MEETING AND REPORTED TO THE BOARD. FORM 990, PART VI, SECTION C, LINE 19 MOFFITT RESEARCH MAKES AVAILABLE TO THE PUBLIC THROUGH DAC BOND, THIRD PARTY VENDORS' WEBSITE AND MOFFITT'S WEBSITE THE CONSOLIDATED AUDITED FINANCIAL STATEMENTS. IN ADDITION FORM 990 IS MADE AVAILABLE ON GUIDESTAR AS WELL AS ON MOFFITT'S WEBSITE. ALL ORGANIZING AND GOVERNING DOCUMENTS SUCH AS FORM 1023, CONFLICTS OF INTEREST POLICY, AND BYLAWS AS WELL AS FORM 990 AND AUDITED FINANCIAL STATEMENTS ARE MADE AVAILABLE UPON REQUEST. FORM 990, PART VI, SECTION B, LINE 16B: THE ORGANIZATION HAS ADOPTED A WRITTEN JOINT VENTURE PROCEDURE WITH WHICH IT COMPLIES. IN MARCH 2021, MOFFITT ENTERED INTO A LIMITED PARTNERSHIP AGREEMENT WITH CERTAIN INVESTORS TO FORM M2GEN HOLDINGS, L.P. WHERE THE CANCER CENTER'S OUTSTANDING EQUITY INTEREST IN M2GEN, CORP. WAS EXCHANGED FOR A PARTNERSHIP INTEREST IN M2GEN HOLDINGS, L.P. THE CANCER CENTER OWNS 4,375 PARTNERSHIP UNITS IN THE NEWLY FORMED M2GEN HOLDINGS, L.P. (WHICH IS APPROXIMATELY 18.6% OF OUTSTANDING PARTNERSHIP UNITS). THE CANCER CENTER DOES NOT HAVE THE ABILITY TO EXERCISE SIGNIFICANT INFLUENCE OVER THE OPERATING AND FINANCIAL DECISIONS OF M2GEN HOLDINGS, L.P. M2GEN OPERATIONS INVOLVE ONCOLOGY-FOCUSED HEALTH INFORMATICS SOLUTIONS WITH THE MISSION TO HELP PATIENTS GET ACCESS TO THE BEST TREATMENTS BY LEVERAGING CLINICAL AND MOLECULAR DATA TO TAILOR PERSONALIZED THERAPIES. ON AN ONGOING BASIS, FOR NEW AND EXISTING ARRANGEMENTS SUCH AS THIS, MOFFITT FOLLOWS PROCEDURES THAT REQUIRE THE EVALUATION OF ITS PARTICIPATION IN THESE ARRANGMENTS AND TAKES ANY NECESSARY STEPS TO SAFEGUARD ITS EXEMPT STATUS. FORM 990, PART IX, COLUMN (D): THERE ARE NO FUNDRAISING EXPENSES BECAUSE H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE FOUNDATION, INC. HANDLES ALL FUNDRAISING ACTIVITIES FOR H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE, INC. AND ITS SUBSIDIARIES. FORM 990, PART IX, LINE 24B CERTAIN MOFFITT CANCER CENTER INTERCOMPANY OVERHEAD HAS BEEN ALLOCATED FROM THE PARENT ENTITY TO THE SUBSIDARY ENTITIES AND THOSE AMOUNTS ARE INCLUDED IN COLUMN (C) AND THEN REALLOCATED ON LINE 24B TO THE PROPER FUNCTIONAL CATEGORIES. FORM 990, PART XI, LINE 9: TRANSFER TO/FROM AFFILIATED ORGANIZATION (CASH) 177,836,469. CHANGE IN INTEREST IN NET ASSETS OF FOUNDATION 7,811,712. GRANT REFUNDS -2,325,477. INTEREST FROM THE CIGARETTE TAX TRUST FUND 8,174. EQUITY INVESTMENT IN TURNSTONE 2,000,000. DECONSOLIDATION OF ONCOBAY -4,706,607. H LEE MOFFITT CANCER CTR & RESEARCH INSTITUTE HOSPITAL INC 12902 MAGN0LIA DRIVE TAMPA FL 33612 593238634 PATIENT CARE FL 501(C)(3) LINE 3 H LEE MOFFITT CANCER CTR & RES INST INC 1 H LEE MOFFITT CANCER CTR & RESEARCH INSTITUTE FOUNDATION INC 12902 MAGN0LIA DRIVE TAMPA FL 33612 593238636 FUNDRAISING FL 501(C)(3) LINE 7 H LEE MOFFITT CANCER CTR & RES INST INC 1 H LEE MOFFITT CC&RI LIFETIME CANCER SCREENING CENTER INC 12902 MAGN0LIA DRIVE TAMPA FL 33612 593238640 PRACTICE MANAGEMENT FL 501(C)(3) LINE 10 H LEE MOFFITT CANCER CTR & RES INST INC 1 MOFFITT REAL ESTATE HOLDING CORP (EFF 010123) 12902 MAGNOLIA DRIVE TAMPA FL 33612 923387708 HOLDING TITLE FL 501(C)(2) H LEE MOFFITT CANCER CTR & RES INST INC 1 MOFFITT LIFESCIENCES CAMPUS MANAGEMENT CORPORATION (EFF 01012023) 12903 MAGNOLIA DRIVE TAMPA FL 33613 923388291 REAL ESTATE PROPERTY MANAGEMENT FL 501(C)(3) LINE 12A, I H LEE MOFFITT CANCER CTR & RES INST INC 1 MOFFITT TECHNOLOGIES CORPORATION 12902 MAGNOLIA DRIVE TAMPA FL 33612 300332914 TECHNOLOGY MANAGEMENT FL H LEE MOFFITT CC&RI INC C -35 262621 1.00000 1 ONCOBAY CLINICAL INC (UNTIL 012023) 9650 STRICKLAND ROAD SUITE 103-150 RALEIGH NC 27615 843412796 RESEARCH & PRODUCT DEVELOPMENT FL H LEE MOFFITT CC&RI INC C -91508 1.00000 1 1 1 1 0 0 0 0 0 0 0 0 1 1 1 0 1 1 0 1 H LEE MOFFITT CC&RI HOSPITAL INC B 398225 FMV H LEE MOFFITT CC&RI HOSPITAL INC C 20576930 FMV H LEE MOFFITT CC&RI FOUNDATION INC C 20458215 FMV H LEE MOFFITT CC&RI FOUNDATION INC Q 1892950 FMV ONCOBAY CLINICAL INC P 348382 FMV ONCOBAY CLINICAL INC A 100 FMV ONCOBAY CLINICAL INC A 42892 FMV